Why don't we know how antidepressants work yet?
Antidepressants are widely prescribed and life-changing for some patients, yet their precise mechanisms — and even what “depression” is biologically — remain poorly understood. Commenters weigh the benefits and harms of SSRIs and other psychoactive drugs, highlighting delayed effects, withdrawal risks, misdiagnosis, and large groups for whom treatments fail or backfire. Many point to the broader limits of psychiatry, the trial‑and‑error nature of current practice, and the influence of profit incentives on which therapies are researched and promoted.
Limits of Current Psychiatric Knowledge
- Several commenters argue we don’t understand the brain well enough for a full theory of how antidepressants work; psychiatry is seen as incomplete but the best available.
- Others note this is common in medicine: many effective drugs (SSRIs, lithium, Tylenol, anesthetics, alcohol) have partially or poorly understood mechanisms.
Efficacy and Individual Variability
- Multiple personal accounts say antidepressants were life‑saving or enabled basic functioning (e.g., agoraphobia, severe depression).
- Others report no benefit, severe side effects, or long‑term complications (e.g., dystonia after Effexor).
- Some stress that “they work” should be understood as “they worked for me”; non‑response and harm are real.
- Treatment‑resistant depression and genetic differences in drug response are mentioned, including tests that predict poor SSRI response for some.
Mechanism, Time Lag, and Theories
- The weeks‑long delay for SSRIs is frequently cited as evidence they act via downstream adaptations, not just “more serotonin.”
- Commenters mention receptor downregulation, changes in brain structure, and neurotrophic factors as hypotheses, but emphasize uncertainty.
- Some question whether “depression” is a single disease rather than a cluster of syndromes with different causes.
Risks, Suicide, and Withdrawal
- Discussion of increased suicide risk early in treatment: motivation may return before mood improves, enabling action on suicidal thoughts.
- Sudden SSRI cessation is described as worsening depression and causing “brain zaps”; tapering is strongly advised.
- Concerns are raised about GP knowledge gaps in psychiatric meds and withdrawal (especially benzodiazepines).
- Benzos and alcohol withdrawal are noted as potentially dangerous or fatal.
Broader Models of Distress
- Distinctions are drawn between biological depression, situational depression/despair, and normal sadness.
- Economic and life stressors are seen as major drivers in some cases, which drugs may not fix.
- Some highlight the gut–brain axis and vagus nerve as emerging but poorly understood contributors.
Pharma, Profit, and Research Priorities
- Commenters argue there is more incentive to sell symptom‑treating drugs and “superfoods” than to fund hard basic science.
- Cheap options like lithium are seen as under‑researched despite strong effects and serious side‑effect profiles (notably kidney risk).